Archive for May, 2012

Researchers use their ‘noodles’: nanotechnology for regenerative medicine

Author: Angela C. H. McDonald, 05/29/12

Nanotechnology has been a buzzword in the medical technology community for some time. It is defined as the manipulation and use of microscopic structures at the molecular scale, generally 1-100 nanometres in size (1 nanometre is 1 billionth of a metre, which translates to approximately 1 billionth the length of a baseball bat!) Nanotechnology is…Read more

Pleasantly surprised at World Stem Cells congress

Author: David Kent, 05/24/12

As a basic researcher in stem cell biology, one of my biggest fears is moving too quickly with cell therapies that involve primitive, still largely mysterious, cell populations. At the World Stem Cells & Regenerative Medicine Congress meeting this week, I felt much better about the direction that regenerative medicine is headed. It has been…Read more

Like a cell without its media

Author: Stacey Johnson, 05/24/12

My grandfather was a mathematician and chemical engineer who worked on the Manhattan Project. I dated a chemical engineer for two years. Those two associations are the full breadth of my understanding of this field of science. Apparently I took chemistry in high school, but I don’t remember a thing. A classmate assures me I…Read more

Strategies to boost regenerative medicine: Growing an extra layer of skin

Author: David Kent, 05/22/12

You might expect this article to be about creating skin grafts for burn victims or something of that ilk. Instead though, it concerns the complicated process of taking a scientific discovery in regenerative medicine and bringing that discovery through clinical trials or commercialization to help people. If you imagine the middle of an onion as…Read more

Cells as drugs: Health Canada approves mesenchymal stem cell based treatment

Author: Paul Krzyzanowski, 05/22/12

Many readers may already have heard of Health Canada’s approval of Osiris’ Prochymal, a mesenchymal stem cell treatment for severe cases of pediatric Graft versus Host Disease (GvHD), with plenty of coverage circulating around the web. GvHD is a disease where transplanted bone marrow generates an immune system that attacks cells of the recipient.  The…Read more

Federal Government proposes amendments to Canada’s embryo research law

Author: Ubaka Ogbogu, 05/18/12

The Federal Government has proposed amendments to the Assisted Human Reproduction Act, the legislation that governs embryo research, including many aspects of stem cell research. The amendments, which are contained in an omnibus budget implementation bill tabled before Parliament on April 26, seeks primarily to implement the 2010 Supreme Court of Canada ruling that invalidated…Read more

Welcome to our new niche!

Author: Stem Cell Network, 05/16/12

Welcome to Signals Blog, the new home and new name for the Stem Cell Network Blog. Why the change? After nearly four years, 207 blog posts and several “best of” awards, the SCN Blog finally outgrew its dish, so to speak. Late last year, we began planning with the newly-formed Centre for Commercialization of Regenerative Medicine,…Read more

View from the floor 6: Research outside of academia

Author: Paul Krzyzanowski, 05/16/12

Commercialization plenary summary: part 4 of 4 The last speaker of the commercialization plenary at the Till and McCulloch Meetings earlier this month was Dr. Stephen Minger from GE Healthcare, who shared GE’s perspective regarding the therapeutic and research potential of human stem cells. Previous to his role at GE Healthcare, Minger was the director…Read more

2012 Cells I See winners

Author: Stem Cell Network, 05/11/12

  By all accounts, the 35 entries in this year’s Cells I See Art Contest & Gallery Showing were among the best we’ve ever had. Certainly, there were more than we’d ever seen before (view them all here) — so many, in fact, that we had to clear an entire lounge space at the host hotel just…Read more

View from the floor 5: Pushing the boundaries with technology

Author: David Kent, 05/08/12

  The final day of the 2012 Till and McCulloch Meetings was packed with great science, but a common theme definitely emerged – technological advances are changing the way we think about and perform scientific research. Keynote speaker Helen Blau issued a warning about trying to mimic the stem cell niche outside the body, using an entertaining…Read more